David Cory Net Worth & Insider Trades
David Cory - President and CEO, Eiger Biopharmaceuticals, Inc
What is David Cory's Net Worth?
The current estimated net worth of Eiger Biopharmaceuticals, Inc's President and CEO, David Cory, is estimated to be about $81.13K . David Cory owns about 96,126 units of Eiger Biopharmaceuticals, Inc common stock. In the last 6 years at Eiger Biopharmaceuticals, Inc, David Cory has sold an estimated value of $0 worth.
What is David Cory's Past Insider Trading?
David Cory's largest purchase order was 1,562 units , worth over $24.52K on August 19, 2016. In total, David Cory has made about 11 transactions over 6 years of their time at Eiger Biopharmaceuticals, Inc. David Cory usually trades in March, with the busiest year in 2019. The most recent transaction was a purchase order of 343 units , worth over $3.86K on April 26, 2019.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
David Cory
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What was David Cory's Salary in 2020?
As President and CEO of Eiger Biopharmaceuticals, Inc, David Cory has a total base salary of $590,584 . David Cory received compensation valued at about $1,830,179 in 2020 after becoming President and CEO. The vast majority of their compensation came in the form of option awards of $829,564 , other earnings, plans or compensations of $393,360 , and other compensation of $16,671 .
What is David Cory's' Mailing Address?
- Mailing address is 350 Cambridge Avenue, Suite 350 Palo Alto CA 94306 CA
Eiger Biopharmaceuticals, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| David A. Cory | 2020 | $590,584 | - | - | $829,564 | $393,360 | $16,671 | $1,830,179 |
| David A. Cory | 2019 | $565,833 | - | - | $2,009,820 | $285,000 | $11,200 | $2,871,853 |
| Sriram Ryali | 2020 | $381,550 | - | - | $234,442 | $173,272 | $12,296 | $801,559 |
| Sriram Ryali | 2019 | $335,000 | - | - | $662,211 | $117,250 | $9,732 | $1,124,193 |
| Eldon Mayer | 2020 | $385,569 | $100,000 | $92,700 | $1,199,520 | $169,256 | $2,328 | $1,949,373 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1305253/000119312521137193/d146195ddef14a.htm
What are Eiger Biopharmaceuticals, Inc's Past Insider Trades?
Eiger Biopharmaceuticals, Inc's most recent insider trade came on March 21, 2023 by Eldon C. Mayer III who sold 4,395 units worth $4.7K . In the last 7 years, insiders at Eiger Biopharmaceuticals, Inc have sold an estimated value of $3.06M and bought an estimated value of $4.81M worth of shares. Insider trading is most common in March, with the busiest year in 2019. The most active traders at the company are Thomas J. Dietz, Eldon C. Mayer III, Ex VP & Chief Commerc. Officer, and Jeffrey S Glenn .
Eiger BioPharmaceuticals, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||